Home-HF: Evaluation of Patients With Heart Failure Using Home Telemonitoring
Home-HF: a Randomised Controlled Evaluation of Home Telemonitoring of Patients With Heart Failure Recently Discharged From Hospital.
2 other identifiers
interventional
182
1 country
3
Brief Summary
This project, using home monitoring for the signs and symptoms of heart failure, aims to empower patients to be actively involved in their care and provide rapid access to healthcare services and advice when needed. The telemonitoring system is easy to use and ensures the accurate transfer of information from the home to the hospital. The information is then screened and if important changes are seen, the patient will be contacted by a heart failure nurse who will offer advice and may arrange a clinic visit or suggest alterations to the medication. The project uses modern technology to provide disease management, links the patient in their home with the hospital and reinforces education and self-care behaviour. This innovative programme will be tested to see if it reduces the risk of re-admission to hospital, reduces anxiety, improves quality of life following a hospital admission for heart failure and whether this represents good value for money in terms of the health benefits it provides. Hypothesis: Patients using home telemonitoring of signs and symptoms of heart failure following discharge from hospital with chronic heart failure have a reduced risk of all-cause re-hospitalisation when compared with usual care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_3 heart-failure
Started May 2006
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 7, 2006
CompletedFirst Posted
Study publicly available on registry
April 11, 2006
CompletedStudy Start
First participant enrolled
May 1, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2008
CompletedResults Posted
Study results publicly available
May 30, 2016
CompletedMay 30, 2016
November 1, 2007
2.3 years
April 7, 2006
October 27, 2015
April 26, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Days Alive and Outside of Hospital
Days alive and outside of hospital (i.e. not admitted)
From date of randomisation for 180 days
Patients Hospitalised (All Cause)
From randomisation date to 180 days
Number of Days Spent in Hospital
From randomisation date for 180 days
Number of Hospitalisations (All Cause)
from randomisation for 180 days
Study Arms (2)
Usual Care
ACTIVE COMPARATORRecieved usual hospital and community care
Intervention Arm
EXPERIMENTALRecieved telemonitoring
Interventions
The HomMed telemonitoring system allows for patients to monitor their weight, blood pressure, oxygen saturation and symptoms of dyspnoea on a daily basis from their home
Eligibility Criteria
You may qualify if:
- NYHA class II - IV (i.e. breathlessness at rest or on mild-moderate exercise) at time of randomisation (hospital discharge)
- Proven diagnosis of heart failure, in line with the guidelines for management of chronic heart failure of the European Society of Cardiology or as determined by the cardiologist or physician caring for the patient
- Admission to hospital following a new diagnosis of heart failure or episode of acute decompensation of chronic heart failure
- Home telephone line
- Deemed fit for discharge home by the clinical team
You may not qualify if:
- Dementia/confusion which is likely to interfere with the use of the HomMed telemonitoring equipment.
- \< 18 years of age
- Lack of home telephone line
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Imperial College Londonlead
- Honeywell HomMedcollaborator
Study Sites (3)
West Middlesex University Hospital
Greater London, Middlesex, TW7 6AF, United Kingdom
Ealing Hospital
London, UB1 3HW, United Kingdom
Hillingdon Hospital
Uxbridge, UB8 3NN, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Professor Cowie
- Organization
- Imperial College london
Study Officials
- PRINCIPAL INVESTIGATOR
Martin R Cowie, MD MSc FRCP
Imperial College London & Royal Brompton and Harefield Hospital NHS Trust
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 7, 2006
First Posted
April 11, 2006
Study Start
May 1, 2006
Primary Completion
September 1, 2008
Study Completion
September 1, 2008
Last Updated
May 30, 2016
Results First Posted
May 30, 2016
Record last verified: 2007-11